...
首页> 外文期刊>Pharmacognosy Research >Mast cell stabilization potential of Sitopaladi churna: An ayurvedic formulation
【24h】

Mast cell stabilization potential of Sitopaladi churna: An ayurvedic formulation

机译:Sitopaladi churna的肥大细胞稳定潜力:阿育吠陀制剂

获取原文

摘要

Background:Sitopaladi churna (SPC) is a popular polyherbal ayurvedic formulation used in the treatment of allergy and respiratory diseases.Objective:The present study was aimed to justify the classical use of antiallergic claim by performing the mast cell stabilizing activity of extracts of SPC.Materials and Methods:The protective effect of aqueous extract and methanolic extract - of SPC against compound 48/80-induced mast cell degranulation model was carried out.Results:Sitopaladi churna aqueous extract (SPCA) at the dose of 300 mg/kg and Sitopaladi churna methanolic extract (SPCM) at the doses of 150 and 300 mg/kg showed better protection of mast cell degranulation (65%-74%) and were comparable to the standard drug ketotifen (79%), when peritoneal mast cells were treated with compound 48/80. The protection against mast cell degranulation was significant (P < 0.0001).Conclusion:From the above results, it has been justified that SPC can be used to treat allergic disorders.
机译:背景:Sitopaladi churna(SPC)是一种用于治疗过敏和呼吸系统疾病的流行的多草药阿育吠陀制剂。目的:本研究旨在通过执行SPC提取物的肥大细胞稳定活性来证明抗过敏声称的经典用途。材料与方法:水提取物和甲醇提取物-SPC对化合物48/80诱导的肥大细胞脱粒模型具有保护作用。结果:300 mg / kg剂量的西托帕拉地栗水提取物(SPCA)和西托帕拉地当用腹膜肥大细胞治疗时,浓度为150和300 mg / kg的秋葵甲醇提取物(SPCM)显示出对肥大细胞脱粒的更好保护(65%-74%),与标准药物酮替芬(79%)相当。化合物48/80。肥大细胞脱粒的保护作用很明显(P <0.0001)。结论:从以上结果可以证明,SPC可用于治疗过敏性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号